The window of opportunity on a takeover at $1B or less may be shut out very quickly. Shares on issue post capital raise are 1,105,000 (expected), so offer would be at around the 90c mark or in the vicinity of a 50% premium to the share price when it reopens to trading. Nothing to sneeze at but given the circumstances of a heavily cashed up explorer, highly prospective tenement, now revealing high grade and generally under-explored at depth, an aggressive (nothing to lose) management style and a rampaging POG, I would humbly suggest a 50% premium maybe not be enough at this opportune time for Spartan.
Next assays will likely tell the story. More good hits at NN and confirmation that Pepper is not a one hit wonder and we are off to the races - the 60 and 70cent levels could be taken out in a couple of sessions imo. Of course, if the assays don’t pan out as we’d like, a 90c takeover would look very appealing.
My opinions only.
- Forums
- ASX - By Stock
- Ann: A$80m Fully Underwritten Equity Raising to Accelerate Explor
SPR
spartan resources limited
Add to My Watchlist
1.50%
!
$2.03

The window of opportunity on a takeover at $1B or less may be...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.03 |
Change
0.030(1.50%) |
Mkt cap ! $2.582B |
Open | High | Low | Value | Volume |
$2.01 | $2.05 | $2.01 | $2.147M | 1.060M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 134979 | $2.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.03 | 53176 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 195842 | 2.010 |
27 | 170110 | 2.000 |
11 | 33119 | 1.995 |
12 | 76378 | 1.990 |
7 | 20043 | 1.985 |
Price($) | Vol. | No. |
---|---|---|
2.020 | 54030 | 17 |
2.030 | 147302 | 25 |
2.040 | 95631 | 20 |
2.050 | 54568 | 21 |
2.060 | 33636 | 12 |
Last trade - 11.08am 27/06/2025 (20 minute delay) ? |
Featured News
SPR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online